Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (7)
  • Penn Non-Treatment Trials (4)
  • Phase 1: Solid Tumor Trials (0)
  • Proton Therapy Trials (3)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
UPCC 24309 Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas II Proton Therapy Not Applicable
UPCC 23811 A Phase 2 Study of Dovitinib in Adults With Advanced Malignant Pheochromocytoma or Paraganglioma II Signal Transduction Inhibitor dovitinib
CDX110-06 A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma II Immunotherapy, Signal Transduction Inhibitor bevacizumab; sargramostim; rindopepimut; KLH Pulsed Dendritic Cell Vaccine
UPCC 08309 Proton Radiation for Low Grade Gliomas I / II Proton Therapy Not Applicable
CDR0000579896 Phase I/II Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma I / II Chemotherapy temozolomide; iniparib
ABTC-1101 A Phase I Open Label Safety Study to Evaluate the Pharmacokinetic Profile and Tolerance of Mibefradil Dose Finding in Subjects With Recurrent High-Grade Glioma Undergoing Standard, Repeated Temozolomide Treatment I Chemotherapy, Other temozolomide
UPCC 08310 Detection of Vascular and Neuronal Changes Following Proton and/or Photon Radiotherapy in Patients Receiving Skull Base and/or Brain Radiation Not Specified Proton Therapy Not Applicable
Displaying: 1 - 7 of 7 Results
  • < Previous
  • 1
  • Next >